PeopleBio Inc
PeopleBio, Inc., a biotech company, engages in developing diagnostics for protein misfolding diseases worldwide. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. The company has strategic collaborations with Seoul National University Bundang Hosp… Read more
PeopleBio Inc - Asset Resilience Ratio
PeopleBio Inc (304840) has an Asset Resilience Ratio of 5.72% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how PeopleBio Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down PeopleBio Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩1.13 Billion | 5.72% |
| Total Liquid Assets | ₩1.13 Billion | 5.72% |
Asset Resilience Insights
- Limited Liquidity: PeopleBio Inc maintains only 5.72% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
PeopleBio Inc Industry Peers by Asset Resilience Ratio
Compare PeopleBio Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
InBody Co.Ltd
KQ:041830 |
Healthcare Equipment & Supplies | 20.98% |
|
MEDIANA Co.Ltd
KQ:041920 |
Healthcare Equipment & Supplies | 39.47% |
|
Value Added Technology Co. Ltd
KQ:043150 |
Healthcare Equipment & Supplies | 3.34% |
|
MEKICS Co Ltd
KQ:058110 |
Healthcare Equipment & Supplies | 5.91% |
|
Meta Biomed Co. Ltd
KQ:059210 |
Healthcare Equipment & Supplies | 11.86% |
|
INFINITT Healthcare Co. Ltd
KQ:071200 |
Healthcare Equipment & Supplies | 61.76% |
|
i-SENS Inc
KQ:099190 |
Healthcare Equipment & Supplies | 6.17% |
|
Sewoon Medical Co. Ltd
KQ:100700 |
Healthcare Equipment & Supplies | 9.67% |
Annual Asset Resilience Ratio for PeopleBio Inc (2017–2024)
The table below shows the annual Asset Resilience Ratio data for PeopleBio Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 23.61% | ₩6.39 Billion | ₩27.07 Billion | +4.60pp |
| 2023-12-31 | 19.01% | ₩5.24 Billion | ₩27.58 Billion | -34.26pp |
| 2022-12-31 | 53.27% | ₩22.54 Billion | ₩42.32 Billion | -22.54pp |
| 2021-12-31 | 75.82% | ₩38.93 Billion | ₩51.35 Billion | -12.08pp |
| 2020-12-31 | 87.89% | ₩9.37 Billion | ₩10.65 Billion | +18.68pp |
| 2019-12-31 | 69.22% | ₩3.02 Billion | ₩4.36 Billion | -20.33pp |
| 2018-12-31 | 89.55% | ₩5.84 Billion | ₩6.52 Billion | +13.86pp |
| 2017-12-31 | 75.69% | ₩1.80 Billion | ₩2.38 Billion | -- |